Artilysin®: Fearless Into the Post-antibiotic Era
To counter this threat, Lysando AG has developed the so-called Artilysin technology: Novel antimicrobial proteins with a unique mode of action.
- To counter this threat, Lysando AG has developed the so-called Artilysin technology: Novel antimicrobial proteins with a unique mode of action.
- View the full release here: https://www.businesswire.com/news/home/20221215005034/en/
Lysando AG has developed the so-called Artilysin technology: Novel antimicrobial proteins with a unique mode of action. - The Artilysin technology allows the Lysando team to design fit-for-purpose molecules by flexibly combining modules with antibacterial activity.
- Moreover, the technology for example in topical applications acts locally, does not breach the body's natural barriers or disrupt our skin's natural defense system.